Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 27;8(3):e2723. doi: 10.1097/GOX.0000000000002723

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Fig. 3. — Microscopic observation of changes in fibrillin-1 expression on days 3 and 8 after injection. The increase in fibrillin-1 expression in the papillary dermis is shown following VYC-12L and HYD treatment as enhanced green immunofluorescence as compared with control. Nuclei are counterstained in red. HYD, noncrosslinked hyaluronic acid with mannitol; VYC-12L, crosslinked hyaluronic acid injectable gel with lidocaine.